Reneo Pharmaceuticals, Inc. (RPHM) has a market capitalization of $60.84M and trades at $18.20. The 52-week range is 1.68-82.9.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -4.1, Earnings Per Share (EPS) of $-4.40.
The stock has a beta of 0.22, operates in the Healthcare sector.
